Experience with lacosamide in the treatment of status epilepticus;Erfahrungen mit Lacosamid in der Behandlung des Status epilepticus

Aktuelle Neurologie

Volumn 39, Issue 8, 2012, Pages 425-428

  Rantsch, K ^a   Pohley, I ^a   Benecke, R ^a   Rosche J ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

lacosamide; status epilepticus; success rate

Indexed keywords

HARKOSERIDE;

ANGIONEUROTIC EDEMA; ATRIOVENTRICULAR BLOCK; EPILEPTIC STATE; HUMAN; MEDLINE; REVIEW; SKIN ALLERGY; TREATMENT OUTCOME;

EID: 84867900805     PISSN: 03024350     EISSN: 14389428     Source Type: Journal    
DOI: 10.1055/s-0032-1311558     Document Type: Review

References (27)

1. Rosenow F., Hamer H. M., Knake S. The epidemiology of convulsive and nonconvulsive status epilepticus. Epilepsia: 2007; 48 08 82 84 (Pubitemid 350045535)
2. Kälviäinen R. Status epilepticus treatment guidelines. Epilepsia: 2007; 48 08 99 102 (Pubitemid 350045540)
3. Kurthen M., Janzen RW C., Lerche H. et al. Leitlinien der DGN Status epilepticus im Erwachsenenalter. http://www.dgn.org/inhalte-a-z/507-leitlinien- der-dgn-status-epilepticus-im-erwachsenenalter (03.07.2011)
4. Shorvon S., Baulac M., Cross H. et al. The drug treatment of status epilepticus in Europe: Consensus document from a workshop at the first London Colloquium on Status Epilepticus. Epilepsia: 2008; 49 1277 1284
5. Meierkord M., Boon P., Engelsen B. et al. EFNS guideline on the management of status epilepticus in adults. Eur J Neurol: 2010; 17 348 355
6. Chen LL K., Haneff Z., Dorsch A. et al. Successful treatment of refractory simple motor status epilepticus with lacosamide and levetiracetam. Seizure: 2011; 20 263 265
7. Kellinghaus C., Berning S., Besselmann M. Intravenous lacosamide as successful treatment for nonconvulsive status epilepticus after failure of first-line therapy. Epilepsy Behav: 2009; 14 429 431
8. Tilz C., Resch R., Hofer T. et al. Successful treatment for refractory convulsive status epilepticus by non-parenteral lacosamide. Epilepsia: 2010; 51 316 317
9. Turpín-Fenoll L., Millán-Pascual J., Navarro-Muoz S. et al. Uso de lacosamida oral en un pacíente con estado epileptico parcial refractario. Rev Neurol: 2010; 50 603 606
10. Rösche J., Schley A., Schwesinger A. et al. Recurrent aphasic status epilepticus after prolonged generalized tonic-clonic seizures versus a special feature of Todds paralysis. Epilepsy Behav: 2011; 20 132 137
11. Shiloh-Malawski Y., Fan Z., Greenwood R. et al. Successful treatment of childhood prolonged refractory status epilepticus with lacosamide. Seizure: 2011; 20 586 588
12. Laroche S. M., Shivdat-Nanhoe R. Subacute encephalopathy and seizures in alcoholics (SESA) presenting with non-convulsive status epilepticus. Seizure: 2011; 20 505 508
13. Krause L. U., Brodowski K. O., Kellinghaus C. Atrioventricular block following lacosamide intoxication. Epilepsy Behav: 2011; 20 725 727
14. Wittstock M., Benecke R., Rösche J. Transient third-degree atrioventricular block following rapid lacosamide titration in a patient with nonconvulsive status epilepticus. Epileptologia: 2011
15. Granda-Méndez J., Toledo M., Flores-Flores A. et al. Lacosamida intravenosa en monoterapia en un caso de estado epileptico parcial complejo. Rev Neurol: 2011; 53 61 63
16. Torres-Cano N., Giner-Bayarri P., Chilet-Chilet M. R. et al. Estado epiléptico non convulsivo persistente. Rev Neurol: 2011; 53 255 256
17. Kellinghaus C., Berning S., Immisch I. et al. Intravenous lacosamide for treatment of status epilepticus. Acta Neurol Scan: 2011; 123 137 141
18. Koubeissi M. Z., Mayor C. L., Estephan B. et al. Efficacy and safety of intravenous lacosamide in refractory nonconvulsive status epilepticus. Acta Neurol Scan: 2011; 123 142 146
19. Parkerson K. A., Reinsberger C., Chou S. H. et al. Lacosamide in the treatment of acute recurrent seizures and periodic epileptiform patterns in critically ill patients. Epilepsy Behav: 2011; 20 48 51
20. Goodwin H., Hinson H. E., Shermock K. M. et al. The use of lacosamide in refractory status epilepticus. Neurocrit Care: 2011; 14 348 353
21. Albers J. M., Möddel G., Dittrich R. et al. Intravenous lacosamide An effective add-on treatment of refractory status epilepticus. Seizure: 2011; 20 428 430
22. Rantsch K., Walter U., Wittstock M. et al. Efficacy of intravenous lacosamide in refractory nonconvulsive status epilepticus and simple partial status epilepticus. Seizure: 2011; 20 529 532
23. Höfler J., Unterberger I., Dobesberger J. et al. Intravenous lacosamide in status epilepticus and seizure clusters. Epilepsia: 2011; 52 e148 e152
24. Kellinghaus Ch. Lacosamide as treatment for partial epilepsy: mechanisms of action, pharmacology, effects, and safety. Ther Clin Risk Manag: 2009; 5 757 766
25. Eriksson K., Metsäranta P., Huhtala H. et al. Treatment delay and the risk of prolonged status epilepticus. Neurology: 2005; 65 1316 1318 (Pubitemid 41508236)
26. DeLorenzo R. J., Towne A. R., Pellock J. M. et al. Status epilepticus in children, adults, and the elderly. Epilepsia: 1992; 33 04 15 25
27. Towne A. R., Pellock J. M., Ko D. et al. Determinants of mortality in status epilepticus. Epilepsia: 1994; 35 27 34 (Pubitemid 24074462)